1. Expression of Bak and Bak/Mcl-1 ratio can predict photodynamic therapy outcome for oral verrucous hyperplasia and leukoplakia.
- Author
-
Yu CH, Chen HM, Lin HP, and Chiang CP
- Subjects
- Adult, Aged, Aminolevulinic Acid therapeutic use, Biomarkers analysis, Biopsy, Caspase 3 analysis, Caspase 8 analysis, Caspase 9 analysis, Cyclin-Dependent Kinase Inhibitor p21 analysis, Epithelial Cells pathology, Female, Humans, Hyperplasia, Keratins analysis, Leukoplakia, Oral pathology, Male, Middle Aged, Mouth Mucosa pathology, Myeloid Cell Leukemia Sequence 1 Protein, Photosensitizing Agents therapeutic use, Proliferating Cell Nuclear Antigen analysis, Remission Induction, Treatment Outcome, Tumor Suppressor Protein p53 analysis, Young Adult, Leukoplakia, Oral drug therapy, Mouth Mucosa drug effects, Photochemotherapy methods, Proto-Oncogene Proteins c-bcl-2 analysis, bcl-2 Homologous Antagonist-Killer Protein analysis
- Abstract
Background: Our previous studies showed that topical 5-aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) is very effective for oral verrucous hyperplasia (OVH) and relatively less effective for oral leukoplakia (OL) lesions. Nevertheless, there has been no report on the association of the expression of apoptosis-related proteins in OVH and OL biopsy tissues prior to PDT with PDT treatment outcomes., Methods: This study used immunohistochemistry to evaluate whether the expression of Bak, Mcl-1, caspase-3, caspase-8, caspase-9, p53, p21, or PCNA protein in biopsy specimens of OVH and OL lesions could be used to predict the clinical outcomes of 18 OVH and 40 OL lesions treated with topical ALA-PDT. The marker labeling score (LS) was defined as labeling index (positive cells/total cells) multiplied by staining intensity. The lesions after ALA-PDT treatment were divided into complete response (CR) group and partial or no response (PR/NR) group., Results: The mean Bak LS and the mean Bak/Mcl-1 LS ratio were significantly higher in the CR group than in the PR/NR group. However, there was no significant difference in the Mcl-1, caspase-3, caspase-8, caspase-9, p53, p21, or PCNA protein LS between the CR and PR/NR groups., Conclusion: We conclude that the Bak LS or Bak/Mcl-1 LS ratio may be a useful biomarker to predict the clinical outcomes of OVH and OL lesions treated with topical ALA-PDT. Pre-PDT epithelial cell levels of Mcl-1, caspase-3, caspase-8, caspase-9, p53, p21, and PCNA may not have a significant influence on the clinical outcome of OVH and OL lesions treated with topical ALA-PDT., (© 2012 John Wiley & Sons A/S. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF